Stock Fundamentals

Company Information

Company Name
Rezolute Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US76200L3096
CIK: 0001509261
CUSIP: 76200L309
Currency: USD
Full Time Employees: 75
Phone: 650 206 4507
Fiscal Year End: June
IPO Date: May 01, 2014
Description:

Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. Its lead clinical asset is ersodetug, an intravenously administered human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder, as well as for the treatment of hypoglycemia; and clinical trials of ersodetug for tumor hyperinsulinism. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.

Address:

275 Shoreline Drive, Redwood City, CA, United States, 94065

Directors & Officers

Name Title Year Born
Mr. Nevan Charles Elam J.D. Founder, CEO, Principal Financial Officer & Acting Chairman of the Board 1967
Mr. Daron G. Evans M.B.A., M.S. Chief Financial & Business Officer 1974
Dr. Brian Kenneth Roberts M.D. Chief Medical Officer 1975
Dr. Davelyn Eaves Hood M.B.A., M.D. Director and Head of Scientific & Patient Affairs NA
Mr. Michael R. Deperro Senior VP & Head of Corporate Development NA
Mr. Michael Covarrubias Senior VP & Head of Program & Portfolio Management NA
Mr. Chris Milks VP & Head of Finance NA
Dr. Raj Agrawal M.D. VP & Head of Ophthalmological Clinical Development NA
Ms. Robyn Sweinhart VP & Head of Quality NA
Ms. Erin O'Boyle Senior VP & Head of Clinical Operations NA

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Federated Hermes Inc 14.03M Sep 30, 2025 14.67% $0.23 0.00%
RA Capital Management, LLC 9.18M Dec 31, 2025 9.59% $0.22 0.00%
Opaleye Management Inc 6.29M Dec 31, 2025 6.57% $1.96 595.91%
BlackRock Inc 5.00M Sep 30, 2025 5.23% $0.00 22.61%
Vanguard Group Inc 4.79M Dec 31, 2025 5.00% $0.00 8.58%
Balyasny Asset Management LLC 4.51M Dec 31, 2025 4.71% $0.01 147.26%
Blackstone Inc 3.02M Sep 30, 2025 3.16% $0.11 -15.07%
Mangrove Partners 2.88M Sep 30, 2025 3.01% $2.00 25.45%
Marshall Wace Asset Management Ltd 2.73M Sep 30, 2025 2.85% $0.03 -5.48%
UBS Group AG 2.70M Sep 30, 2025 2.82% $0.00 -11.23%
Great Point Partners LLC 2.45M Sep 30, 2025 2.56% $9.50 -19.17%
Affinity Asset Advisors, LLC 2.35M Dec 31, 2025 2.46% $0.32 11.96%
FMR Inc 2.31M Dec 31, 2025 2.41% $0.00 -81.94%
State Street Corp 2.09M Sep 30, 2025 2.19% $0.00 151.96%
Integral Health Asset Management, LLC 2.00M Sep 30, 2025 2.09% $1.27 11.11%
Geode Capital Management, LLC 1.85M Sep 30, 2025 1.93% $0.00 7.97%
Vestal Point Capital LP 1.69M Dec 31, 2025 1.76% $0.14 0.00%
Bank of America Corp 1.28M Sep 30, 2025 1.34% $0.00 1,578.50%
Point72 Asset Management, L.P. 1.16M Sep 30, 2025 1.21% $0.02 447.22%
22NW, LP 820.65K Sep 30, 2025 0.86% $3.63 0.00%

Shares Statistics

Shares Outstanding: 95.70M
Shares Float: 65.54M
% Insiders: 1,024.40%
% Institutions: 9,620.20%
Short % Float: 26.60%

🏆 Top 10 Institutional Holders

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Federated Hermes Inc 14.03M 14.67% ▲ 0.00% Sep 30, 2025
2 RA Capital Management, LLC 9.18M 9.59% ▲ 0.00% Dec 31, 2025
3 Opaleye Management Inc 6.29M 6.57% ▲ 595.91% Dec 31, 2025
4 BlackRock Inc 5.00M 5.23% ▲ 22.61% Sep 30, 2025
5 Vanguard Group Inc 4.79M 5.00% ▲ 8.58% Dec 31, 2025
6 Balyasny Asset Management LLC 4.51M 4.71% ▲ 147.26% Dec 31, 2025
7 Blackstone Inc 3.02M 3.16% ▼ 15.07% Sep 30, 2025
8 Mangrove Partners 2.88M 3.01% ▲ 25.45% Sep 30, 2025
9 Marshall Wace Asset Management Ltd 2.73M 2.85% ▼ 5.48% Sep 30, 2025
10 UBS Group AG 2.70M 2.82% ▼ 11.23% Sep 30, 2025

Valuation Metrics

Enterprise Value: $117.16M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $248.34M
EBITDA: $-88.38M
Book Value: $1.23
Earnings/Share: $-0.93
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -44.09%
ROE (TTM): -74.02%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Earnings History

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-06-30 14.37x 0.00x 0.08x N/A -0.01x
2024-06-30 13.39x 0.00x 0.09x N/A -0.01x
2023-06-30 20.18x 0.00x 0.06x -60.92x -0.01x
2022-06-30 61.78x 0.00x 0.02x -23.16x -0.01x
2021-06-30 21.34x 0.55x 0.39x -61.05x -0.69x
2020-06-30 3.26x 0.03x 0.33x -1,710.08x -0.01x
2019-06-30 1.45x 0.01x 0.86x -5.23x 0.00x
2018-06-30 0.32x -0.87x 2.58x -41.69x -0.14x
2017-06-30 2.78x 0.00x 0.20x -12,742.35x 0.00x
2016-06-30 2.60x 0.01x 0.20x -2,967.11x -0.01x
2015-06-30 3.59x 0.03x 0.20x -1,589.82x -0.02x
2014-06-30 6.54x 0.01x 0.13x -1.22x -0.01x
2013-06-30 0.15x -0.90x 4.77x -10.74x -0.61x
2012-06-30 0.49x 0.00x 2.05x N/A 0.00x

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Dec 15, 2025 Daron Evans N/A Purchase 40.00K $1.77 $70.80K
Dec 15, 2025 Daron Evans N/A Purchase 5.00K $1.79 $8.95K
Dec 15, 2025 Nevan C Elam N/A Purchase 32.00K $1.59 $50.88K
Dec 15, 2025 Sunil Ratilal Karnawat N/A Purchase 12.10K $1.62 $19.60K
Jun 25, 2025 Brian Kenneth Roberts N/A Purchase 2.50K $4.38 $10.95K
Jun 24, 2025 Daron Evans N/A Purchase 5.00K $4.05 $20.25K
Jun 13, 2025 Nerissa Kreher N/A Purchase 3.08K $3.25 $10.00K
Jun 13, 2025 Young-Jin Kim N/A Purchase 1.23M $3.25 $4.00M
Mar 31, 2025 Wladimir Hogenhuis N/A Purchase 6.76K $2.92 $19.73K
Mar 27, 2025 Nevan C Elam N/A Purchase 12.30K $2.85 $35.06K
Mar 26, 2025 Daron Evans N/A Purchase 10.00K $2.89 $28.90K

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about RZLT.US!